Share chart Chimeric Therapeutics Limited
Extended chart
Simple chart
About Chimeric Therapeutics Limited
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. more details| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.chimerictherapeutics.com |
| Цена ао | 0.001 |
| Change price per day: | 0% (0.001) |
|---|---|
| Change price per week: | 0% (0.001) |
| Change price per month: | 0% (0.001) |
| Change price per 3 month: | 0% (0.001) |
| Change price per half year: | 0% (0.001) |
| Change price per year: | -96.67% (0.03) |
| Change price per year to date: | 0% (0.001) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD | Founder & Executive Chairman | 1956 (69 years) | |
| Mr. Jason B. Litten M.D. | Chief Medical Officer | 1974 (51 year) | |
| Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A. | CFO, Joint Company Secretary & Director | 1959 (66 years) | |
| Dr. Rebecca McQualter | Chief Operating Officer | ||
| Mr. Kelly R. Thornburg | VP & Head of Quality | 1963 (62 years) | |
| Mr. Nathan Jong C.A. | Company Secretary |
Address: Australia, Carlton, 62 Lygon Street - open in Google maps, open in Yandex maps
Website: https://www.chimerictherapeutics.com
Website: https://www.chimerictherapeutics.com
